We are live on
!
Find out more
ZIC
ZWJ Investment Counsel Portfolio holdings
AUM
$3.09B
1-Year Est. Return
39.43%
This Fund
S&P 500
This Quarter
Est. Return
+14.65%
1 Year Est. Return
+39.43%
3 Year Est. Return
+115.09%
5 Year Est. Return
+149.82%
10 Year Est. Return
+2,238.52%
AUM
$1.47B
AUM Growth
+$224M
(+18%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
4.32%
Top 10 Holdings %
Top 10 Hldgs %
31.42%
Holding
164
New
21
Increased
97
Reduced
19
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$16.9M |
| 2 |
Boston Scientific
BSX
|
+$11.9M |
| 3 |
DISH
DISH Network Corp.
DISH
|
+$10.5M |
| 4 |
International Flavors & Fragrances
IFF
|
+$5.66M |
| 5 |
Roper Technologies
ROP
|
+$2.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$8.15M |
| 2 |
TotalEnergies
TTE
|
+$6.31M |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$6.02M |
| 4 |
Outfront Media
OUT
|
+$4.82M |
| 5 |
Genuine Parts
GPC
|
+$954K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.87% |
| 2 | Healthcare | 14.45% |
| 3 | Financials | 13.51% |
| 4 | Consumer Staples | 10.58% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNV
151
DELISTED
Synovus
SNV
| $263K | 0.02% |
+8,133
| New | +$235K |
|
152
iShares MSCI EAFE ETF
EFA
$80.2B
| $250K | 0.02% |
+3,425
| New | +$234K |
|
153
Morgan Stanley
MS
$342B
| $243K | 0.02% |
+3,546
| New | +$203K |
|
154
JB Hunt Transport Services
JBHT
$25.9B
| $239K | 0.02% |
1,750
| – | – |
|
155
Netflix
NFLX
$309B
| $220K | 0.02% |
+4,070
| New | +$206K |
|
156
Medtronic
MDT
$116B
| $218K | 0.01% |
+1,860
| New | +$205K |
|
157
Stryker
SYK
$133B
| $215K | 0.01% |
+877
| New | +$199K |
|
|
NVO
158
Novo Nordisk
NVO
$203B
| $214K | 0.01% |
+6,120
| New | +$212K |
|
159
Clorox
CLX
$12.8B
| $207K | 0.01% |
1,025
| – | – |
|
160
Schwab 1000 Index ETF
SCHK
$5.94B
| $204K | 0.01% |
+10,902
| New | +$192K |
|
|
BMY.RT
161
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $126K | 0.01% |
181,864
-3,385
| -2% | -$7.21K |
|
|
162
Agios Pharmaceuticals
AGIO
$2.04B
| – | – |
-171,982
| Closed | -$6.02M |
|
163
Oneok
OKE
$58.3B
| – | – |
-11,720
| Closed | -$304K |
|
|
PARA
164
DELISTED
Paramount Global Class B
PARA
| – | – |
-291,051
| Closed | -$8.15M |
|
Similar funds
HCM
TCG
CAM
MRCP
PC
ECP
CCI
DIG
ZWJ Investment Counsel's Q4 2020 Portfolio in Review
As of Q4 2020, ZWJ Investment Counsel held 164 positions worth $1.47B, up 18% from $1.25B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
ZWJ Investment Counsel deployed $63.5M of net new capital in Q4 2020, opening 21 new positions and adding to 97 existing holdings. Its largest new stake was Chubb: 120,655 shares worth $18.6M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was TotalEnergies, an estimated $6.31M trimmed.
- ZWJ Investment Counsel's largest Q4 2020 buy was Chubb: 120,655 shares worth $18.6M.
- ZWJ Investment Counsel added most to Boston Scientific in Q4 2020, an estimated $11.9M increase.
- ZWJ Investment Counsel's biggest Q4 2020 reduction was TotalEnergies, cutting an estimated $6.31M.
- ZWJ Investment Counsel fully exited Paramount Global Class B in Q4 2020, selling an estimated $8.15M.
- ZWJ Investment Counsel's ten largest holdings make up 31% of its $1.47B portfolio in Q4 2020.
- ZWJ Investment Counsel opened 21 new positions and closed 3 in Q4 2020.
- ZWJ Investment Counsel's portfolio value rose 18% quarter-over-quarter to $1.47B.
Based on ZWJ Investment Counsel's 13F filing for Q4 2020, filed 26 Feb 2021.